The Influence of Treatment Strategies on Cognitive Functions in Patients with Paroxysmal and Persistent Atrial Fibrillation
To assess the cognitive functions (CF) in patients with atrial fibrillation (AF) depending on the treatment strategy and the features of outpatient care, we have examined 96 patients. Management of patients was carried out in two common strategies: the rehabilitation and subsequent maintenance of sinus rhythm (SR), and preservation of AF with control of heart rate (HR). At the first stage, we have studied the factors influencing the choice of treatment strategy in patients hospitalized with AF paroxysm. The specialized scales were used to evaluate the tolerance of the AF, СF level, anxiety and depression. The second phase consisted in the outpatient monitoring of patients. The patients were randomized into two following groups: 1 — group of active follow-up, 2 — group of standard follow-up. The choice of treatment strategy in patients with AF was determined by factors such as age, alcohol abuse, the size of the left atrium, the form of AF (paroxysmal/persistent), as well as the wishes of the patient. During the direct survey, as the most important factors when choosing the strategy of HR control, doctors indicated the duration of AF attack more than 1 year and satisfactory tolerability of the AF. When deciding about how to restore SR, the most important were the desire of the patient, the absence of significant dilation of the left atrium, rare (less than 4 times a year) paroxysms and young age of patients. СF of patients with AF, whose treatment is carried out within the strategy of HR control, was significantly lower than in patients, who restore and maintain SR. In addition, among this group of patients the prevalence of depression was significantly higher. Dynamics of CF in patients with AF did not depend on the treatment strategies, but depended on the sex, baseline CF, the nature of outpatient care and social factors (living without family). Patients with higher level of CF had greater adherence to the treatment and were less prone to self-cancellation of amiodarone (during 24 months of follow-up).
Full Text:PDF (Українська)
Оганов Р.Г. Депрессии и расстройства депрессивного спектра в общемедицинской практике / Р.Г. Оганов, Л.И. Ольбинская, А.Б. Смулевич // Кардиология. — 2004. — № 1. — С. 48-54.
Cherr G.S. Patients with depression are at increased risk for secondary cardiovascular events after lower extremity revascularization / G.S. Cherr, Р.М. Zimmerman, J. Wang, H.H. Dosluoglu // J. Gen. Intern. Med. — 2008. — Vol. 23(5). — Р. 629-634.
Dietary Guidelines for Americans. — Washington, DC: US Government Printing Office, 2005. — Р. 43-46.
Dorian P. A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: The CCS SAF scale / P. Dorian, S.S. Cvitkovic, C.R. Kerr // Can. J. Cardiol. — 2006. — Vol. 22. — P. 383-286.
Dorian P. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy / P. Dorian, W. Jung, D. Newman // J. Am. Coll. Cardiol. — 2000. — Vol. 36. — P. 1303-1309.
Frasure-Smith N. Atrial Fibrillation and Congestive Heart Failure Investigators. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure / N. Frasure-Smith, F. Lespérance, M. Habra // Circulation. — 2009. — Vol. 14. — 134-140.
Frasure-Smith N. Anxiety sensitivity moderates prognostic importance of rhythm control versus rate control strategies in patients with atrial fibrillation and congestive heart failure: insights from theAtrial Fibrillation and Congestive Heart Failure Trial / N. Frasure-Smith, F. Lespérance, M. Talajic // Circ. Heart. Fail. — 2012. — Vol. 5(3). — Р. 322-330.
Go A.S. Prevalence ofdiagnosed atrial fi brillation in adults: national implicationsfor rhythm management and stroke prevention: the AnTicoagulationand Risk Factors in Atrial Fibrillation (ATRIA)Study / A.S. Go, E.M. Hylek, K.A. Phillips // JAMA. — 2001. — Vol. 285. — Р. 2370-2375.
Miyasaka Y. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota,1980 to 2000, and implications on the projections for future prevalence / Y. Miyasaka, M.E. Barnes, B.J. Gersh // Circulation. — 2006. — Vol. 114. — Р. 119-125.
Naccarelli G.V. Increasing prevalence of atrial fibrillation and flutter in the United States / G.V. Naccarelli, H. Varker, J. Lin, K.L. Schulman // Am. J. Cardiol. — 2009. — Vol. 104. — Р. 1534-1539.
Pedersen S.S. Brief depressions creening with the PHQ‑2 associated with prognosis following percutaneous coronary intervention with paclitaxel-eluting stenting / S.S. Pedersen, J. Denollet, Р. de Jonge // J. Gen. Intern. Med. — 2009. — Vol. 24(9). — Р. 1037-1042.
Reynolds M.R. Quality of Life in Atrial Fibrillation: Measurement Tools and Impact ofInterventions / M.R. Reynolds, Е. Ellis, Р. Zimetbaum // J. Cardiovasc. Electrophysiol. — 2008. — Vol. 19(7). — Р. 762-768.
Rollman B.L. A positive 2-item Patient Health Questionnaire depression screen among hospitalized heart failure patients is associated with elevated 12-month mortality / B.L. Rollman, B. Herbeck Belnap, S. Mazumdar // J. Card. Fail. — 2012. — Vol. 18(3). — Р. 238-245.
Stewart S. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study / S. Stewart, C.L. Hart, D.J. Hole, J.J. McMurray // Heart. — 2001. — Vol. 86. — P. 516-521.
Thrall G. Depression, Anxiety, and Quality of life in patients with Artrial Fibrillation / G. Thrall, G.Y.H. Lip, D. Carrol // Chest. — 2007. — Vol. 132. — Р. 1259-1264.
Van den Berg M.P. Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system / M.P. Van den Berg, R.J. Hassink, А.Е. Tuinenburg // Eur. Heart J. — 2001. — Vol. 22. — Р. 247-253.
Copyright (c) 2016 EMERGENCY MEDICINE
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2020